{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:19:33Z","timestamp":1791231573459,"version":"4.1.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01858","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T05:46:05Z","timestamp":1565156765000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid"],"prefix":"10.3389","volume":"10","author":[{"given":"Meriem","family":"Riani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Bour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Antonicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Le Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1346-8138.2001.tb00055.x","article-title":"Bullous pemphigoid: end of the century overview","volume":"28","author":"Liu","year":"2001","journal-title":"J Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous pemphigoid: a review of its diagnosis, associations and treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.4049\/jimmunol.1100596","article-title":"Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice","volume":"187","author":"Hirose","year":"2011","journal-title":"J Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.4049\/jimmunol.169.7.3987","article-title":"Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation","volume":"169","author":"Chen","year":"2002","journal-title":"J Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000365946","article-title":"Comparison of CD163+ CD206+ M2 macrophages in the lesional skin of bullous pemphigoid and pemphigus vulgaris: the possible pathogenesis of bullous pemphigoid","volume":"229","author":"Furudate","year":"2014","journal-title":"Dermatology (Basel)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1172\/JCI117196","article-title":"92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen","volume":"93","author":"St\u00e5hle-B\u00e4ckdahl","year":"1994","journal-title":"J Clin Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1100\/2011\/213962","article-title":"Macrophage polarization in health and disease","volume":"11","author":"Cassetta","year":"2011","journal-title":"Sci World J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.7150\/ijbs.8879","article-title":"Macrophage polarization in inflammatory diseases","volume":"10","author":"Liu","year":"2014","journal-title":"Int J Biol Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrrheum.2016.91","article-title":"Macrophage heterogeneity in the context of rheumatoid arthritis","volume":"12","author":"Udalova","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1189\/jlb.0406249","article-title":"Biochemical and functional characterization of three activated macrophage populations","volume":"80","author":"Edwards","year":"2006","journal-title":"J Leukoc Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6861","DOI":"10.4049\/jimmunol.166.11.6861","article-title":"Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors","volume":"166","author":"Gerber","year":"2001","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1038\/jid.2014.263","article-title":"Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid","volume":"134","author":"Le Jan","year":"2014","journal-title":"J Invest Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/srep18001","article-title":"Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome","volume":"5","author":"Pl\u00e9e","year":"2015","journal-title":"Sci Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jaci.2016.08.012","article-title":"Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes","volume":"139","author":"Riani","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/jid.2008.310","article-title":"Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction","volume":"129","author":"Tjiu","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1515\/bchm.1997.378.3-4.265","article-title":"Binding of 92 kDa and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation","volume":"378","author":"Emonard","year":"1997","journal-title":"Biol Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"35517","DOI":"10.18632\/oncotarget.21216","article-title":"Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid","volume":"9","author":"Qiao","year":"2018","journal-title":"Oncotarget."},{"key":"B24","first-page":"331","article-title":"Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity","volume":"111","author":"Musson","year":"1983","journal-title":"Am J Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0301-472X(00)00143-0","article-title":"1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro","volume":"28","author":"Berer","year":"2000","journal-title":"Exp Hematol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fphar.2018.00071","article-title":"Convenience versus biological significance: are PMA-differentiated THP-1 cells a reliable substitute for blood-derived macrophages when studying in vitro polarization?","volume":"9","author":"Tedesco","year":"2018","journal-title":"Front Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molimm.2017.05.027","article-title":"THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro","volume":"88","author":"Shiratori","year":"2017","journal-title":"Mol Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage m1-m2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/JAA.S104508","article-title":"Update on the role of alternatively activated macrophages in asthma","volume":"9","author":"Jiang","year":"2016","journal-title":"J Asthma Allergy."},{"key":"B30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-0625.1998.tb00317.x","article-title":"Decreased interleukin-7 and transforming growth factor-beta1 levels in blister fluids as compared to the respective serum levels in patients with bullous pemphigoid. Opposite behavior of TNF-alpha, interleukin-4 and interleukin-10","volume":"7","author":"Giacalone","year":"1998","journal-title":"Exp Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2133.1998.02169.x","article-title":"Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity","volume":"138","author":"Ameglio","year":"1998","journal-title":"Br J Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF02507102","article-title":"Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid","volume":"288","author":"Schmidt","year":"1996","journal-title":"Arch Dermatol Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.4049\/jimmunol.1600066","article-title":"IL-10 enhances IgE-mediated mast cell responses and is essential for the development of experimental food allergy in IL-10-deficient mice","volume":"196","author":"Polukort","year":"2016","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1684\/ejd.2018.3366","article-title":"Immunoglobulin E and bullous pemphigoid","volume":"28","author":"Cozzani","year":"2018","journal-title":"Eur J Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0166433","DOI":"10.1371\/journal.pone.0166433","article-title":"Alternatively activated (M2) macrophage phenotype is inducible by Endothelin-1 in cultured human macrophages","volume":"11","author":"Soldano","year":"2016","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/path.4133","article-title":"Macrophage plasticity and polarization in tissue repair and remodelling","volume":"229","author":"Mantovani","year":"2013","journal-title":"J Pathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12026-012-8291-9","article-title":"Macrophage polarization and plasticity in health and disease","volume":"53","author":"Biswas","year":"2012","journal-title":"Immunol Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000489163","article-title":"Bullous pemphigoid associated with adalimumab therapy in a patient with ulcerative colitis","volume":"10","author":"Hoffmann","year":"2018","journal-title":"Case Rep Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jdcr.2017.03.008","article-title":"Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitis","volume":"3","author":"Wessman","year":"2017","journal-title":"JAAD Case Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jdcr.2015.12.006","article-title":"Etanercept-induced generalization of chronic, localized, anogenital bullous pemphigoid in a psoriatic patient","volume":"2","author":"Wilmer","year":"2016","journal-title":"JAAD Case Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000318008","article-title":"Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports","volume":"221","author":"Boussemart","year":"2010","journal-title":"Dermatology (Basel)."},{"key":"B42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000243805","article-title":"Bullous pemphigoid during long-term TNF-alpha blocker therapy","volume":"219","author":"Bordignon","year":"2009","journal-title":"Dermatology (Basel)."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01858\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T05:46:07Z","timestamp":1565156767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01858\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2019.01858"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01858","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]},"article-number":"1858"}}